| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Molly Harper | Director | 2025-12-12 | 15,527 | $23.20 | $360.20kSell |
| Molly Harper | Director | 2025-12-12 | 6,746 | $23.06 | $155.56kSell |
| Molly Harper | Director | 2025-12-12 | 4,473 | $23.73 | $106.16kSell |
| Molly Harper | Director | 2025-12-12 | 20,000 | $5.78 | $115.60kBuy |
| Carmen Jeffrey Del | Chief Commercial Officer | 2025-11-26 | 10,983 | $23.33 | $256.24kSell |
| Carmen Jeffrey Del | Chief Commercial Officer | 2025-11-26 | 10,983 | $4.21 | $46.24kBuy |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-11-12 | 40,000 | $22.70 | $908.00kSell |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-08 | 112,475 | $2.24 | $251.94kBuy |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-08 | 30,000 | $20.30 | $609.00kSell |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-04 | 30,000 | $2.24 | $67.20kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.25% | 18,626,781 | $424.50M | Institution |
| Vanguard Group Inc | 6.90% | 8,432,247 | $192.17M | Institution |
| State Street Corp | 5.66% | 6,907,622 | $157.42M | Institution |
| Biomarin Pharmaceutical Inc | 5.46% | 6,666,667 | $151.93M | Insider |
| Deerfield Management Company LP | 4.02% | 4,911,161 | $111.93M | Institution |
| Patrick J. McEnany | 3.77% | 4,609,324 | $105.05M | Insider |
| Hubert E. Md Huckel | 3.11% | 3,793,238 | $86.45M | Insider |
| Fundsmith LLP | 2.75% | 3,363,807 | $76.66M | Institution |
| American Century Companies Inc | 2.48% | 3,025,271 | $68.95M | Institution |
| Dimensional Fund Advisors LP | 2.45% | 2,996,297 | $68.29M | Institution |